Federal Register Notice: FDA is amending a notice of meeting of the 11/9 Nonprescription Drugs Advisory Committee to change the location and contact name from DoubleTree by Hilton Hotel Washington DC/Silver Spring, Silver Spring, MD to FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room, (Rm. 1503), Silver Spring, MD. Contact Minh Doan, (301) 796-9001. The meeting is scheduled to discuss an MSD Consumer Care, Inc. NDA for the partial switch from prescription to OTC of the oxybutynin transdermal system to treat overactive bladder in women. To view this notice, click here.